ProQR Therapeutics (PRQR) Share-based Compensation (2013 - 2022)

ProQR Therapeutics' Share-based Compensation history runs 10 years deep, the most recent figure standing at -$394835.7 for Q4 2022.

• In Q4 2022, Share-based Compensation fell 119.38% year-over-year to -$394835.7; the TTM figure through Dec 2022 stood at $3.1 million (down 58.21% YoY), while the FY2025 annual figure was $4.7 million, up 71.88% from the prior year.
• Share-based Compensation came in at -$394835.7 for Q4 2022 at ProQR Therapeutics, down from $1.3 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $5.0 million in Q4 2019 to a low of -$394835.7 in Q4 2022.
• A 5-year average of $1.4 million and a median of $1.4 million in 2019 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation surged 242935.54% in 2019 and plunged 119.38% in 2022, its largest moves.
• ProQR Therapeutics' Share-based Compensation stood at $3615.9 in 2018, then soared by 137467.21% to $5.0 million in 2019, then plunged by 64.29% to $1.8 million in 2020, then grew by 14.69% to $2.0 million in 2021, then slumped by 119.38% to -$394835.7 in 2022.
• According to Business Quant data, Share-based Compensation over the past three periods registered -$394835.7, $1.3 million, and $787487.8 for Q4 2022, Q3 2022, and Q2 2022 respectively.

Peer Comparison